Back to Grants
Health Open for ApplicationsPAR-25-026

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health opportunity PAR-25-026

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-026Grants.gov
Related Grants
Funding Amount
Varies
USD
Application Deadline
7 January 2027
97 days remaining
Opens: 5 Dec 2024
Programme Details
Programme Code
PAR-25-026